TABLE 1.
Overall (N = 163) | Initial Cohort (n = 120) | Validation Cohort (n = 43) | P Value | |
---|---|---|---|---|
Age, mean ± SD, y | 16.7 ± 3.0 | 17.0 ± 2.9 | 16.0 ± 3.3 | >.05 |
Weight, mean ± SD, kg | 67.1 ± 16.4 | 67.6 ± 16.1 | 65.8 ± 17.6 | >.05 |
Height, mean ± SD, cm | 167.6 ± 11.1 | 168.5 ± 10.3 | 165.0 ± 12.9 | >.05 |
Sex, female/male, n | 105/58 | 78 /42 | 27 /16 | >.05 |
Graft type, HS/BPTB/ALLO, n | 95/53/15 | 60/49/11 | 35/4/4 | <.001 |
Time from ACLR to RTS testing, mean ± SD, mo | 8.3 ± 2.5 | 8.1 ± 2.1 | 8.9 ± 3.3 | >.05 |
aACLR, anterior cruciate ligament reconstruction; ALLO, allograft; BPTB, bone–patellar tendon–bone graft; HS, hamstring graft; RTS, return to sport.